Our previous study showed that the selective PPARD agonist seladelpar (MBX-8025) alleviates ethanol-induced liver disease in mice by reducing the total bile acid pool and bile acid concentrations in the liver, small intestine, and systemic circulation, and changes bile acid composition (11). This evidence concerns the gene PPARD and liver disorder.